Novartis immunologist describes the excitement of discovering a promising new immuno-oncology (IO) target in the treatment of acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS).
Caring for a baby with retinopathy of prematurity (ROP) has never been easy. But mother and social visionary Silke Mader has made it her life’s work to ensure that parents dealing with ROP and other complications today get more support than she did.
Advanced Accelerators Applications is working on marrying targeted drug design with nuclear medicine technology to develop drugs that can recognize and treat diseases.
For all too many people living with heart failure, hospitalizations are a recurring part of life, affecting the lives of both patients and their caregivers.
